Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
PainChek Ltd ( (AU:PCK) ) has shared an update.
PainChek Ltd has announced the quotation of 218,495 fully paid ordinary securities on the Australian Securities Exchange (ASX), effective from November 5, 2025. This move reflects the company’s ongoing efforts to strengthen its market presence and provide liquidity to its shareholders, potentially impacting its financial position and stakeholder value positively.
More about PainChek Ltd
PainChek Ltd operates in the healthcare technology industry, focusing on developing innovative pain assessment solutions. The company’s primary product is a digital application that uses artificial intelligence to assess and manage pain, particularly in non-verbal patients, enhancing patient care and clinical outcomes.
Average Trading Volume: 5,123,988
Technical Sentiment Signal: Sell
Current Market Cap: A$96.03M
For an in-depth examination of PCK stock, go to TipRanks’ Overview page.